# Kriya Therapeutics, Inc. — Form D

Kriya Therapeutics, Inc. of MORRISVILLE, NC, a company, filed a Form D exempt-offering notice with the SEC on 2021-07-14. The offering totals $100.0M, of which $100.0M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2021-07-14
- Form: D
- Accession: 0001811209-21-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $100.0M
- Amount sold: $100.0M
- Investors: 36
- Date of first sale: 2021-06-30
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-406240

## Issuer

- Name: Kriya Therapeutics, Inc.
- CIK: 0001811209
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 4105 HOPSON ROAD, MORRISVILLE, NC, 27560
- Phone: (833) 574-9289

## Officers, directors & promoters (21)

| Name | Role | Location |
| --- | --- | --- |
| DANIEL CHEN | Executive Officer | San Mateo, CA |
| James Momtazee | Director | Menlo Park, CA |
| Neelaksh Varshney | Director | Morrisville, NC |
| Michele Stone | Executive Officer | Morrisville, NC |
| Ilan Oren | Director | Morrisville, NC |
| Saira Ramasastry | Director | Raleigh, NC |
| Ryan Gallagher | Director | Corona Del Mar, CA |
| Keith Manchester | Director | Morrisville, NC |
| Katherine Eade | Executive Officer | Morrisville, NC |
| Akshay Rai | Director | Morrisville, NC |
| Shankar Ramaswamy | Director | Morrisville, NC |
| Shankar Ramaswamy | Executive Officer | Morrisville, NC |
| Curt Herberts | Executive Officer | Morrisville, NC |
| Britt Petty | Executive Officer | Morrisville, NC |
| Roger Jeffs | Director | Morrisville, NC |
| Brian Furmanski | Executive Officer | Morrisville, NC |
| Trit Garg | Director | Morrisville, NC |
| Dana Johnson | Executive Officer | Palo Alto, CA |
| Neera Ravindran | Executive Officer | Redwood City, CA |
| Ilise Lombardo | Executive Officer | Redwood City, CA |
| C.R. Sincock | Director | Redwood City, CA |

## Other filings by this issuer (6)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2025-09-10](https://search.stillhousedata.com/formd/0001811209-25-000003) | D/A | $320.8M | $320.8M |
| [2025-08-15](https://search.stillhousedata.com/formd/0001811209-25-000002) | D | $313.3M | $313.3M |
| [2023-07-27](https://search.stillhousedata.com/formd/0001811209-23-000002) | D/A | $432.0M | $361.8M |
| [2022-05-24](https://search.stillhousedata.com/formd/0001811209-22-000001) | D | $300.5M | $270.5M |
| [2020-08-18](https://search.stillhousedata.com/formd/0001811209-20-000002) | D/A | $87.6M | $87.6M |
| [2020-05-19](https://search.stillhousedata.com/formd/0001811209-20-000001) | D | $85.6M | $85.6M |

## More

- [CIK 1811209 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1811209&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001811209-21-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.